# Antelope Therapeutics jobs and careers

> 0 open roles at Antelope Therapeutics as of October 24, 2026. Source: https://www.thejobsmap.com/company/antelope-therapeutics

Antelope Therapeutics is a biotechnology company focused on the development of next-generation Antibody-Drug Conjugates (ADCs) targeting high unmet needs in gastrointestinal oncology (Colorectal, Pancreatic, and Gastric cancers). Founded in 2024, Antelope is led by former executives of Mablink Bioscience and Emergence Therapeutics (both acquired by Eli Lilly in 2023). Our leadership combines deep expertise in ADC platform design with a proven track record in clinical development and business exits. Our lead candidate, ATL-024, is a first-in-class ADC that has successfully completed preclinical proof-of-concept. Data demonstrate a potential best-in-disease profile compared to current ADCs in development for CRC. We are currently advancing ATL-024 toward IND-enabling studies and are open to discussions regarding investment and strategic partnerships.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | France |
| Employees | 1 to 10 |
| Website | https://antelope-tx.com |

## Leadership

- Edouard LEROY, Co-founder & CEO

## Common questions

### Is Antelope Therapeutics hiring right now?

Antelope Therapeutics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Antelope Therapeutics's careers site.

### Where is Antelope Therapeutics headquartered?

Antelope Therapeutics is headquartered in France.

### Who leads Antelope Therapeutics?

Edouard LEROY, Co-founder & CEO, is at the top of Antelope Therapeutics's org chart.

### How do I apply for a job at Antelope Therapeutics?

Pick a role on Antelope Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on Antelope Therapeutics's own careers site, so you apply directly with the employer.